Focused Wealth Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Focused Wealth Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,000	Closed	-$7K	–	747
2018 Q2	$7K	Buy	+8,000	New	+$72K	﹤0.01%	489

Focused Wealth Management's JNP Position: Q3 2018 in Review

Focused Wealth Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 125 shares — an estimated $1K sold.

Focused Wealth Management first reported a position in JNP in Q3 2013 and held it in 20 quarters. The position peaked at $19K in Q3 2013. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

Focused Wealth Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Focused Wealth Management sold 125 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $1K.
Focused Wealth Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
Focused Wealth Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $19K in Q3 2013.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Focused Wealth Management's 13F filing for Q3 2018, filed 13 Nov 2018.